Global Tissue Engineering Market

Global Tissue Engineering Market Size, Share, Growth Analysis, By Material(Synthetic Material, and Biologically Derived Material), By Application(Cord blood & Cell Banking, Gynecology) - Industry Forecast 2024-2031


Report ID: SQMIG35H2236 | Region: Global | Published Date: February, 2024
Pages: 219 | Tables: 66 | Figures: 75

Global Tissue Engineering Market News

  • In September 2022, Researchers at Columbia University developed a technique to engineer functional human lungs using stem cells. The team used a combination of 3D bioprinting and tissue engineering to create a lung-like structure that could potentially be used for transplantation in the future.
  • In June 2022, Scientists at the University of Illinois developed a new bioink that can be used in 3D bioprinting to create functional human organs. The bioink is made from a combination of living cells and a hydrogel that mimics the extracellular matrix, providing a supportive environment for cell growth.
  • In April 2022, A team of researchers at Stanford University developed a 3D-printed biodegradable implant that promotes nerve regeneration. The implant provides a scaffold for nerve growth and gradually dissolves over time, allowing the nerves to regenerate naturally.
  • In November 2021, Scientists at the University of Toronto developed a bioengineered patch that can promote the regeneration of damaged heart tissue. The patch, made from a combination of cells and biomaterials, releases therapeutic proteins that stimulate the growth of new blood vessels and cardiac cells.
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Tissue Engineering Market size was valued at USD 13 Billion in 2021 and is poised to grow from USD 14.39 Billion in 2022 to USD 32.45 Billion by 2030, at a CAGR of 10.7% during the forecast period (2023-2030).

The global tissue engineering market has a competitive landscape characterized by the presence of a mix of established companies, emerging players, and research institutions. The market is driven by technological advancements, research collaborations, product innovations, and strategic partnerships. Here is an elaboration on the competitive landscape of the tissue engineering market. The competitive landscape of the tissue engineering market is dynamic, with companies constantly striving to innovate and improve their products. Key factors for success in this market include technological advancements, strong research and development capabilities, regulatory compliance, intellectual property protection, and strategic partnerships with healthcare providers and biotechnology companies. 'Organogenesis Holdings Inc. (US)', 'Acelity L.P. Inc. (US)', 'Medtronic plc (Ireland)', 'Integra LifeSciences Corporation (US)', 'Stryker Corporation (US)', 'Zimmer Biomet Holdings, Inc. (US)', 'Baxter International Inc. (US)', 'Allergan plc (Ireland)', 'Smith & Nephew plc (UK)', 'Wright Medical Group N.V. (Netherlands)', 'Cook Medical Incorporated (US)', 'MiMedx Group, Inc. (US)', 'Osiris Therapeutics, Inc. (US)', 'Tissue Regenix Group plc (UK)', 'NuVasive, Inc. (US)', 'Cellular Dynamics International (US)', 'Vericel Corporation (US)', 'RepliCel Life Sciences Inc. (Canada)', 'Organovo Holdings, Inc. (US)', 'AlloSource (US)'

The rising incidence of chronic diseases, such as cardiovascular disorders, orthopedic conditions, and organ failures, has been a key driver for the tissue engineering market. Tissue engineering provides potential solutions for tissue and organ repair or replacement, offering improved treatment options for patients with chronic conditions.

Personalized Medicine: The trend towards personalized medicine has had an impact on the tissue engineering market. Tissue engineering allows for the customization of tissues and organs to match individual patient needs, reducing the risk of rejection and improving treatment outcomes. This trend aligns with the growing demand for precision medicine and patient-centric healthcare.

North America held the largest share in 2022, primarily driven by factors such as increased awareness of stem cell therapy and a growing geriatric population. The region also benefits from advanced diagnostic and treatment technologies for chronic diseases, ample availability of private and government funding, and high healthcare expenditures, which contribute to a larger market share.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Tissue Engineering Market

Product ID: SQMIG35H2236

$5,300
BUY NOW GET FREE SAMPLE